Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 6/20 | 0.39 |
| ▸ | LPL | P06858 | 5/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | TYR | P14679 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.32 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.32 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.32 |
| ▸ | STS | P08842 | 1/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL526232 | 1.00 | LIPG (0.39) | LIPGLPLTRPV1MGLLTYR | |
| SCHEMBL14359451 | 0.82 | LIPG (0.47) | LIPGLPLTRPV1MGLLTYR | |
| SCHEMBL1651743 | 0.77 | LIPG (0.54) | LIPGLPLTRPV1MGLLTYR | |
| SCHEMBL13325342 | 0.77 | LIPG (0.54) | LIPGLPLTRPV1MGLLTYR | |
| SCHEMBL26488592 | 0.77 | LIPG (0.54) | LIPGLPLTRPV1MGLLTYR | |
| SCHEMBL4270833 | 0.76 | LIPG (0.41) | LIPGLPLTRPV1MGLLTYR | |
| SCHEMBL12502085 | 0.76 | LPL (0.58) | LIPGLPLTRPV1MGLLTP53 | |
| SCHEMBL1268823 | 0.73 | LIPG (0.44) | LIPGLPLTRPV1MGLLTYR | |
| SCHEMBL995399 | 0.73 | — | — | |
| SCHEMBL15754969 | 0.73 | LPL (0.46) | LIPGLPLTRPV1MGLLTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097735-B2 | Methods for preparing benzodithiophenes | XEROX CORPORATION (US) | 2012-01-17 | — | — | US | disclosed |
| US-20110224402-A1 | METHODS FOR PREPARING BENZODITHIOPHENES | XEROX CORPORATION (US) | 2011-09-15 | — | — | US | disclosed |
| US-7956199-B2 | Methods for preparing benzodithiophenes | XEROX CORPORATION (US) | 2011-06-07 | — | — | US | disclosed |
| US-20110086994-A1 | METHODS FOR PREPARING BENZODITHIOPHENES | XEROX CORPORATION (US) | 2011-04-14 | — | — | US | disclosed |
| US-20100121004-A1 | PURIFICATION PROCESS FOR SEMICONDUCTING MONOMERS | XEROX CORPORATION (US) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086994-A1 | METHODS FOR PREPARING BENZODITHIOPHENES | TST, TPST2, MPST | LIPG 3987/4885LPL 4536/4885TRPV1 3539/4885 |
| US-20110224402-A1 | METHODS FOR PREPARING BENZODITHIOPHENES | TST, TPST2, MPST | LIPG 3987/4885LPL 4536/4885TRPV1 3539/4885 |
| US-20100121004-A1 | PURIFICATION PROCESS FOR SEMICONDUCTING MONOMERS | TERT, ADH1A, PCNA | LIPG 2613/4885LPL 912/4885TRPV1 1920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.